Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

29 recalls · Class I, newest first

Class I · High risk

Launch Sequence Aphrodisia Capsules

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Loud Muscle Science D-1338-2022
Class I · High risk

Launch Sequence Euphoria Capsules

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Loud Muscle Science D-1337-2022
Class I · High risk

Launch Sequence Capsules

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Loud Muscle Science D-1336-2022
Class I · High risk

Artri King Reforzado con Ortiga Omega 3 Tablets

Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain and inflammation.

Completed Chemical / undeclared Walmart Inc D-1157-2022
Class I · High risk

Pink Pussycat SENSUAL ENHANCEMENT capsule

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Pink Toyz D-0785-2022
Class I · High risk

RISE UP RED EDITION Capsules

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Positive Health D-0645-2022
Class I · High risk

Avaphinal Maximum Male Enhancement Sexual Pills

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Walmart Stores D-0725-2022
Class I · High risk

RED MAMMOTH capsules

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Celebrate Today D-0638-2022
Class I · High risk

The Red Pill

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Your Favorite Shop D-0630-2022

Recalls by year